Wolkowicz R, Nolan G P
Department of Microbiology and Immunology, School of Medicine, Stanford University, Stanford, CA, USA.
Gene Ther. 2005 Mar;12(6):467-76. doi: 10.1038/sj.gt.3302488.
Acquired immunodeficiency syndrome (AIDS), caused by human immunodeficiency virus (HIV), kills millions worldwide every year. Vaccines against HIV still seem a distant promise. Pharmaceutical treatments exist, but these are not always effective, and there is increasing prevalence of viral strains with multidrug resistance. Highly active antiretroviral therapy (HAART) consists of inhibitors of viral enzymes (reverse transcriptase (RT) and protease). Gene therapy, first introduced as intracellular immunization, may offer hopes for new treatments to be used alone, or in conjunction with, conventional small molecule drugs. Gene therapy approaches against HIV-1, including suicide genes, RNA-based technology, dominant negative viral proteins, intracellular antibodies, intrakines, and peptides, are the subject of this review.
获得性免疫缺陷综合征(艾滋病)由人类免疫缺陷病毒(HIV)引起,每年在全球导致数百万人死亡。针对HIV的疫苗似乎仍遥不可及。虽然存在药物治疗方法,但这些方法并不总是有效,而且具有多重耐药性的病毒株的流行率正在上升。高效抗逆转录病毒疗法(HAART)由病毒酶(逆转录酶(RT)和蛋白酶)抑制剂组成。基因治疗最初作为细胞内免疫引入,可能为单独使用或与传统小分子药物联合使用的新治疗方法带来希望。针对HIV-1的基因治疗方法,包括自杀基因、基于RNA的技术、显性负性病毒蛋白、细胞内抗体、细胞因子和肽,是本综述的主题。